1 Blizard Institute of Cell and Molecular Science, Queen Mary University of London, London, United Kingdom.
2 Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
3 Postgraduate Medical Institute, Faculty of Medical Science, Anglia Ruskin University, Chelmsford, United Kingdom.
4 Blizard Institute of Cell and Molecular Science, Queen Mary University of London, London, United Kingdom Department of Haemato-Oncology, St. Bartholomew's Hospital, London, United Kingdom s.g.agrawal@qmul.ac.uk.